Yubo International Biotech LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
OQB
SCHEDULE: Yubo International Biotech Converts Debt to Equity, Boosting Chinaone Technology's Stake to 15.1%
Yubo International Biotech Limited converted $2.53 million in debt owed to its beneficial owners into 50.6 million Class A Common Stock shares, increasing Chinaone Technology Limited's beneficial ownership to 15.1%.
OQB
SCHEDULE: Yubo International Biotech Sees Major Stake Increase by Flydragon International and Jun Wang
Flydragon International Ltd and its controlling person, Jun Wang, significantly increased their beneficial ownership in Yubo International Biotech Limited to 48.1% through a private placement that converted company debt into equity.
OQB
Chinaone Technology Limited and its controlling person, Yang Wang, have significantly reduced their beneficial ownership in Yubo International Biotech Ltd by selling 2 million shares of Class A Common Stock.